Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Pittsburgh |
---|---|
Information provided by: | University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT00156429 |
This is a retrospective review of the data available on patients and their family members with HCM and prospective follow-up of this cohort for clinical outcome and diagnostic studies. Genetic samples are being examined in this cohort to determine whether certain to determine whether certain beta-AR polymorphisms as well as other common genetic polymorphisms are associated with different morphological features, such as LVH in patients with HCM and whether these polymorphisms influence the clinical course and outcome in patients with HCM. For that purpose, we will build a database with clinical information including serial echocardiographic measurements for patients with HCM that have regular follow up and test them for beta-AR polymorphisms as well as other common genetic polymorphisms and other known cardiac-related polymorphisms that can potentially contribute to the morphologic differences seen in patients with HCM.
Condition |
---|
Hypertrophic Cardiomyopathy |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Genetic Predictors of Outcome in HCM Patients |
Blood sample for DNA analysis
Estimated Enrollment: | 540 |
Study Start Date: | July 2005 |
Estimated Study Completion Date: | June 2010 |
This is a retrospective review of the data available on patients and their family members with HCM and prospective follow-up of this cohort for clinical outcome and diagnostic studies. Genetic samples are being examined in this cohort to determine whether certain to determine whether certain beta-AR polymorphisms as well as other common genetic polymorphisms are associated with different morphological features, such as LVH in patients with HCM and whether these polymorphisms influence the clinical course and outcome in patients with HCM. For that purpose, we will build a database with clinical information including serial echocardiographic measurements for patients with HCM that have regular follow up and test them for beta-AR polymorphisms as well as other common genetic polymorphisms and other known cardiac-related polymorphisms that can potentially contribute to the morphologic differences seen in patients with HCM.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
patients with HCM
Inclusion Criteria:
Exclusion Criteria:
Contact: Samir F Saba, MD | 412-647-6272 | sabas@upmc.edu |
Contact: Raed Abdelhadi, MD | 412-647-6272 | abdelhadirh@upmc.edu |
United States, Pennsylvania | |
UPMC Presbyterian Hospital | Recruiting |
Pittsburgh, Pennsylvania, United States, 15213 | |
Contact: Pamela M White, RN 412-647-2931 whitepm@upmc.edu | |
Principal Investigator: Samir F. Saba, MD | |
Principal Investigator: Raed Abdelhadi, MD | |
Sub-Investigator: David S. Schwartzman, MD | |
Sub-Investigator: Sandeep Jain, MD | |
Sub-Investigator: Raveen Bazaz, MD | |
Sub-Investigator: William Barrington, MD | |
Sub-Investigator: Susan Brode, MD | |
Sub-Investigator: Barry London, MD | |
Sub-Investigator: Dennis McNamara, MD | |
Sub-Investigator: Jan Nemec, MD | |
Sub-Investigator: Pamela M. White, RN, BSN | |
Sub-Investigator: Andrew Voigt, MD | |
Sub-Investigator: Evan Adelstein, MD | |
Sub-Investigator: Frank Schwender, MD |
Principal Investigator: | Samir F. Saba, MD | University of Pittsburgh |
Responsible Party: | UPMC ( Samir Saba/Director, Cardiac Electrophysiology ) |
Study ID Numbers: | 0507025, 0507025 |
Study First Received: | September 8, 2005 |
Last Updated: | June 3, 2008 |
ClinicalTrials.gov Identifier: | NCT00156429 |
Health Authority: | United States: Institutional Review Board |
genetic testing |
Pathological Conditions, Anatomical Hypertrophy Heart Diseases Cardiomyopathy, Hypertrophic Constriction, Pathologic |
Aortic valve stenosis Aortic Valve Stenosis Cardiomyopathies Heart Valve Diseases |
Aortic Stenosis, Subvalvular Cardiovascular Diseases |